A carregar...
PD-1 axis inhibitors in EGFR and ALK Driven Lung Cancer: Lost cause?
Programmed death axis 1 (PD-1) inhibitors have ushered in a new error of cancer immuno-therapeutics for advanced smoking associated non-small cell lung cancer. Their role in treating EGFR mutant and ALK rearranged lung cancer has yet to be determined.
Na minha lista:
| Publicado no: | Clin Cancer Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5653962/ https://ncbi.nlm.nih.gov/pubmed/27470969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-1401 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|